Quest Diagnostics Incorporated
DGXAction· NYSE· USD
L'essentiel à retenir
- • Dernier cours : 233,01 $US (cours différé)
- • Variation sur 1 an : +36,38 %
- • Type d'actif : Action
- • Place de cotation : NYSE
- • Devise de cotation : USD
- • Clôture précédente : 234,30 $US
Informations
- Symbole
- DGX
- Type
- Action
- Place
- NYSE
- Devise
- USD
- Clôture veille
- 234,30 $US
- Variation 1 an
- +36,38 %
Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum?
Quest Diagnostics' earnings beat, raised 2026 outlook and broad testing demand support momentum, but valuation, debt and margin pressure temper the buy case.
Yahoo Finance · 31/07/2026 · lire l'article ↗
Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026
DGX's broad testing demand, payer access, advanced diagnostics and partnerships support 2026 growth as AI and automation target costs.
Yahoo Finance · 30/07/2026 · lire l'article ↗
Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics
Women who test positive for bacterial vaginosis (BV) were over three times more likely to also test positive for one or more non-viral sexually transmitted infections (STIs) than women who test negative for BV, according to a new Health Trends® study from Quest Diagnostics (NYSE: DGX) and Hologic, Inc.
Yahoo Finance · 30/07/2026 · lire l'article ↗
Why Quest Diagnostics Stock Climbed This Past Week
Demand for medical testing services is rising.
Yahoo Finance · 27/07/2026 · lire l'article ↗
Why Quest Diagnostics (DGX) Is Up 8.2% After Raising 2026 Guidance And Boosting Buybacks
Earlier this week, Quest Diagnostics reported second-quarter 2026 results showing sales of US$3,043 million and diluted EPS of US$2.84, and raised its full‑year 2026 revenue guidance to US$11.95–US$12.05 billion and reported EPS to US$9.97–US$10.17. The company also continued its long-running capital return program, repurchasing 522,436 shares for US$100 million in the quarter, which supports earnings per share alongside higher‑value advanced diagnostics and growing test volumes. We’ll now...
Yahoo Finance · 26/07/2026 · lire l'article ↗
Quest Diagnostics (DGX) Stock Gets Fair Value Boost After Q2 Beat And Higher Guidance
Quest Diagnostics is back in focus after analysts lifted Fair Value estimates from US$223.44 to US$239.38, a move that has coincided with price targets shifting into the US$245 to US$265 range for more bullish views and into the low US$230s for more cautious ones. These adjustments reflect how analysts are weighing the Q2 beat, higher full year guidance, and ongoing volume and margin debates when refreshing their models. Read on to see what is driving this evolving narrative and how you can...
Yahoo Finance · 26/07/2026 · lire l'article ↗
Titres et résumés fournis par les sources d'origine (flux Yahoo Finance). Cliquez pour lire l'article complet.
Questions fréquentes sur Quest Diagnostics Incorporated
- Quel est le cours actuel de Quest Diagnostics Incorporated ?
- Le dernier cours connu de Quest Diagnostics Incorporated (DGX) est de 233,01 $US (cours différé, fourni à titre informatif). Cette page est mise à jour régulièrement.
- Quelle est la performance de Quest Diagnostics Incorporated sur un an ?
- Sur les 12 derniers mois, Quest Diagnostics Incorporated (DGX) affiche une variation de +36,38 %. Les performances passées ne préjugent pas des performances futures.
- Comment suivre Quest Diagnostics Incorporated dans mon portefeuille ?
- Créez un compte gratuit sur AssetApp, ajoutez DGX à l'un de vos portefeuilles et suivez sa valeur, vos plus-values et son actualité — aux côtés de vos autres actifs.
Actifs similaires
Quest Diagnostics Incorporated : suivre cet actif
Quest Diagnostics Incorporated (DGX) est une action coté sur NYSE en USD. Avec AssetApp, ajoutez DGX à votre portefeuille pour suivre sa valeur, vos gains latents et réalisés, et l'évolution de votre patrimoine — sans dépendre de votre courtier.
Suivre DGX gratuitement